Psychedelic-Assisted Psychotherapy: Considerations in Complexity and Multiplicity
This workshop may serve as an introduction for clinicians to the potential role of psychedelic medicines in the care of complex trauma and dissociation and in intergenerational healing. The presentation will familiarize attendees with the current shift in paradigm from parallel pharmacologic and psychotherapeutic treatments to a new model of psychedelic-assisted psychotherapy. The presenters hope to equip emerging and seasoned clinicians alike with the information necessary to address questions from both colleagues and patients, and to consider the relevance of this emerging therapy to their own practice. The presentation will explore and attempt to answer the following questions:
- For which clients living with complexity and multiplicity is psychedelic-assisted psychotherapy appropriate?
- What are potential benefits and risks of psychedelic-assisted psychotherapy with this population?
- What are contraindications to psychedelic-assisted generally and for those with complexity/multiplicity specifically?
- What are ethical and current legal considerations around access to and provision of psychedelic-assisted psychotherapy?
- What might models of collaboration and shared care between practitioners of established psychotherapies and psychedelic-assisted psychotherapy practitioners look like?
- How might psychedelic medicines contribute to intergenerational healing?
The presentation will not explore the actions of specific psychedelic medicines or review their pharmacokinetics and pharmacodynamics. The presentation will conclude with an exploration of potentials for intergenerational healing. Resources will be provided to further assist interested clinicians in learning more about psychedelic-assisted psychotherapy and its applications.
This session was originally presented as a live conference session in April 2021.
At the conclusion of this session participants will be able to:
- Name two potential benefits of Psychedelic-Assisted Psychotherapy for complex clients
- List two risks of Psychedelic-Assisted Psychotherapy for complex clients
- Identify an ethical and a current legal considerations around psychedelic-assisted therapy
Presenter: Rochelle Sharpe Lohrasbe, PhD, RCC
Presenter Bio: Rochelle Sharpe Lohrasbe, PhD, RCC, is a Registered Clinical Counsellor who holds an MA in Learning and Development and a PhD in Child and Youth Care. Rochelle began her career in forensic psychiatric nursing and she has accumulated more than 30 years of clinical experience in the areas of post-traumatic stress and developmental wounding. In her private clinical practice in British Columbia, Canada, Rochelle sees “children of all ages” who have endured abuse, neglect, and other traumatic/adverse experiences. She is a Sensorimotor Psychotherapy local, regional, and international facilitator and a curriculum/instructional design consultant, an EMDRIA-approved consultant and holds certifications in Clinical Hypnosis, Neuroptimal Neurofeedback and Havening Techniques. Rochelle presents regularly at ISSTD conferences and regional workshops internationally and provides educational workshops for psychotherapists on Trauma and Dissociation. She recently published on the integration of EMDR and SP, and co-authored “Somatic Resources: Sensorimotor Psychotherapy Approach to Stabilising Arousal in Child and Family Treatment” (2017), published in the Australian and New Zealand Journal of Family Therapy.
Presenter: Kate Browning, Dip. Midwifery, BScN, MA, PhD (cand), RN
Presenter Bio: Kate Browning is a psychotherapist and doctoral candidate in clinical psychology, a somatic psychotherapist specialized in trauma and attachment, and a Registered Nurse specialized in mental health and substance use. She is a former licensed and registered midwife, and is extensively trained in subtle energy and consciousness-based healing practices. Kate has worked in a variety of health care and educational settings for over 25 years as a clinician, clinical supervisor, lecturer, consultant, educator, administrator, She has trained in ketamine-assisted psychotherapy at the Orenda Institute and with the Center for Transformational Psychotherapy, and is training in MDMA-assisted psychotherapy for PTSD with the Multidisciplinary Association for Psychedelic Studies, with whom she will be conducting research in 2021-22. Kate is a clinical advisory council member and research clinician for Numinus Wellness Inc., a company dedicated to research and delivery of accessible psychedelic therapies to improve the mental health of all Canadians. She is a founding and board member of the Canadian Psychedelic Association and of the Ketamine-Assisted Psychotherapy Association of British Columbia. Kate has presented at the Family Caregivers Association of Alberta, the Spirit Plant Medicine Conference, and the Psychedelic Psychotherapy Forum.
- 1.50 APAThe International Society for the Study of Trauma and Dissociation is approved by the American Psychological Association to sponsor continuing education for psychologists. The International Society for the Study of Trauma and Dissociation maintains responsibility for this program and its content.
- 1.50 ASWB ACEThe International Society for the Study of Trauma and Dissociation (ISSTD), #1744, is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved as ACE providers. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. ISSTD maintains responsibility for this course. ACE provider approval period: 08/20/2021 – 08/20/2024. Social workers completing this course receive 1.50 continuing education credits.
- 1.50 ISSTD Certificate ProgramThis program is eligible for 1.50 credits in the ISSTD Certificate Program.
"Your Price" above reflects your final price based on your membership status and career level.
- ISSTD defines a student as those enrolled in a program of study leading to a degree or certification in the mental health field and who have an interest in trauma and dissociation.
- ISSTD defines an emerging professional as mental health professionals who have completed an advanced degree and are in the first three years of their career (or first three years after graduation for researchers).
- If you do not fall into one of the above categories please register as Professional/Retired.
These prices are for Tier I countries. For a list of countries by Tier click here. If you are located in a country that falls into Tier II-VI please contact ISSTD at email@example.com to receive the appropriate discount code.